Detailing Efforts of ADC Combinations With Standard of Care Therapies to Shape the Future of Cancer Therapies
- Exploring ongoing combination trails with Trodelvy and standard of care therapies across solid tumor indications
- Evaluating rationale and design of Trodelvy and other ADC-immunotherapy combination therapies
- Breaking down the potential: What is the route forward and potential impact of novel ADC combinations?